Director, Customer Engagement Strategy & Operations, WW Omnichannel & AI at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • Serves as Chief of Staff and trusted strategic business partner to the VP, Omnichannel & AI
  • Dynamic leader capable of driving operational excellence, stakeholder alignment, and coordinated execution
  • Expertise in omnichannel and AI strategies, including strategy definition, OKRs, roadmaps, and investment priorities
  • Experience leading operating cadence, performance management, business reviews, scorecards, budgets, decision logs, and governance
  • Ability to act as integrator and primary liaison across functions (Omnichannel & AI, Brand, ICDx, BI&T, Finance, Medical, Legal, Compliance, Field, agencies)
  • Skilled in clarifying RACI and decision rights for rapid execution
  • Proficiency in running PMO programs: intake/prioritization, scope, dependencies, timelines, RAID/risk registers, status reporting
  • Knowledge of process standardization, governance, playbooks, and adoption across portfolios (Neuroscience & CAR-T, Oncology, CV, Immunology)
  • Expertise in process improvements, operational excellence, change management, training design, and upskilling for AI transformation
  • Ability to establish prioritization and governance mechanisms focused on outcomes
  • Understanding of US and global regulatory, privacy, and data governance standards
  • Experience managing executive office operations: calendar, briefings, pre-reads, talking points, LT agendas, Town Halls, ELT/board materials, action tracking
  • Capability to troubleshoot issues, run war rooms, and drive escalation/resolution
  • Leadership in budget, headcount, and vendor/contract management

Responsibilities

  • Define and strategize the enterprise omnichannel & AI Team’s strategy with the VP and OC & AI leadership team; translate strategy into clear OKRs, roadmaps, and investment priorities aligned to brand imperatives
  • Lead operating cadence and performance management for OC & AI: weekly/monthly/quarterly business reviews, executive scorecards, budget alignment, decision logs, and governance forums; own OKR and performance dashboards
  • Act as the integrator and primary liaison for the OC & AI team across Omnichannel & AI, Brand, ICDx, BI&T, Finance, Medical, Legal, Compliance, Field, and agency partners; clarify RACI and decision rights to enable rapid, consistent execution
  • Run the OC& AI PMO programs that cross OC & AI functions: intake/prioritization, scope, dependencies, timelines; ensure on-time, on-budget delivery with transparent status, RAID/risk registers, and executive-ready reporting. Integrate into the WCx Transformation office governance as needed
  • Drive standardization of omnichannel processes and governance across Neuroscience & CAR-T, Oncology, CV, Immunology, and other portfolios; drive adoption of common playbooks and compliant ways of working
  • Drive process improvements and operational excellence to accelerate speed-to-value for omnichannel & AI team initiatives
  • Champion change management and enablement: design training, playbooks, and adoption metrics; upskill marketers, analytics, and field teams to accelerate AI transformation. Partner and/or delegate to the WCx Change Management team as needed
  • Establish prioritization and governance mechanisms with focus on Omnichannel & AI team outcomes
  • Ensure US and global regulatory, privacy, and data governance standards are harmonized and embedded, partnering closely with Compliance and Legal
  • Manage the VP of Omnichannel & AI’s executive office operations: calendar, briefings, pre-reads, talking points; set agendas for LT meetings and Town Halls; produce ELT/board materials; track actions and follow-ups
  • Troubleshoot cross-team issues; run war rooms for critical topics; drive structured escalation and resolution
  • Lead budget, headcount, and vendor/contract management for OC & AI with Finance

Skills

Omnichannel
AI
Strategy
Operations
OKRs
Roadmaps
Stakeholder Management
Leadership
Customer Engagement

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI